In this inspiring New Year address, Prof. Marcis Leja, the director of the University of Latvia's Institute of Clinical and Preventive Medicine, shares his reflections on the progress made in cancer screening and prevention through the EUCanScreen project. Prof. Leja highlights the team's dedication and achievements while looking ahead to the opportunities and goals for the upcoming year.
#EUCanScreen, #EuropeanCommission, #EU4Health, #BeatCancer, #HealthEquity
The project “Implementation of cancer screening programmes (EUCanScreen)”, LU registration No. ZD2024/21709, is co-funded by the European Union’s EU4Health programme, Grant Agreement No. 101162959. The views and opinions expressed are those of the author(s) and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible.
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959
